Altimmune launched clinical trial of T-COVIDTM, an investigational intranasal immune modulator for treatment of patients with early COVID-19
On Jun. 1, 2020, Altimmune announced the FDA had authorized the Company to proceed with a clinical trial…
On Jun. 1, 2020, Altimmune announced the FDA had authorized the Company to proceed with a clinical trial…
On Jun. 1, 2020, LabCorpᆴ announced that Covance, its drug development business, had created COVID-19 Clinical Trial Connect…
On Jun. 1, 2020, OPKO Health announced the FDA had authorized OPKO to undertake a Phase 2 trial…
On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…
On Jun. 1, 2020, PathGroup announced the availability of a new, minimally-invasive nasal swab collection option as a…
On May 29, 2020, the FDA took steps to further support the development of COVID-19 tests for at-home…
On May 29, 2020, the Oxford Foundry announced support of four new innovative solutions for the OXFO COVID-19…
On May 28, 2020, a team of researchers has generated a developmental map of a key sound-sensing structure…
On May 28, 2020, the Jenner Institute, University of Oxford, UK and Advent Srl ヨ an IRBM company,…
On May 28, 2020, the FDA approved Avid Radiopharmaceuticals’ Tauvid (flortaucipir F18) for intravenous injection, the first drug…
On May 28, 2020, GSK confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant…
On May 28, 2020, the U.S. Dept. of Veterans Affairs (VA) began a national four-year study on the…
On May 28, 2020, Biogen and the Lemelson-MIT Program (LMIT) at the Massachusetts Institute of Technology announced the…
On May 28, 2020, Vaxxas announced that Merck had exercised its option to utilize Vaxxasメ proprietary High Density…
On May 28, 2020, Quest Diagnostics announced it had received emergency use authorization (EUA) from the FDA for…
On May 28, 2020, Roche announced it had initiated of a global phase III, randomised, double-blind, multicentre study…
On May 28, 2020, Atossa Therapeutics announced that it had begun the development of a second COVID-19 program…
On May 27, 2020, the NIH Nutrition Research Task Force (NRTF), armed with insights from the nutrition science…
On May 27, 2020, Heat Biologics announced a collaboration with Waisman Biomanufacturing to establish a partnership for the…
On May 27, 2020, Quest Diagnostics launched a new suite of Return to Work services built around large-scale…
On May 26, 2020, researchers at the Max Planck Institute for Evolutionary Anthropology in Germany and the Karolinska…
On May 26, 2020, Merck and and IAVI, a nonprofit scientific research organization dedicated to addressing urgent, unmet…
On May 26, 2020, the NIH announced a new study that provides an alternative treatment regimen that is…
On May 26, 2020, the FDA approved Amivas’ artesunate for injection to treat severe malaria in adult and…
On May 26, 2020, Royal Philips announced it had received 510(k) clearance from the FDA for its wearable…
On May 26, 2020, GenScript Biotech announced that it had obtained CE-IVD for its SARS-CoV-2 diagnostic products to…
On May 26, 2020, researchers at the University of Exeter Medical School and the UConn School of Medicine…
On May 26, 2020, Merck and and and Ridgeback Biotherapeutics announced a collaboration agreement to develop EIDD-2801, an…
On May 26, 2020, Innovation Pharma reported receiving data from a leading public health research institute showing Brilacidin…
On May 26, 2020, Cerecor and Myriad Genetics announced that levels of novel cytokine, LIGHT, were highly correlated…